Performing Cytoreductive Nephrectomy following Targeted Sunitinib Therapy for Metastatic Renal Cell Carcinoma: A Surgical Perspective

Publisher： Karger

E-ISSN： 1423-0399|89|1|83-88

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.89, Iss.1, 2012-05, pp. : 83-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delayed Cytoreductive Nephrectomy Following Three Years of Targeted Therapy for Metastatic Renal Cell Carcinoma

By  

Current Urology, Vol. 9, Iss. 4, 2016-12 ,pp. : 202-208

Karger

Access to resources Recommend Favorite

Cytokine Therapy Response as a Selection Criterion for Cytoreductive Nephrectomy in Metastatic Renal Clear-Cell Carcinoma of Intermediate Prognosis

By  

Urologia Internationalis, Vol. 80, Iss. 4, 2008-06 ,pp. : 367-371

Karger

Access to resources Recommend Favorite

Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 736-740

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment to Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 740-741

John Wiley & Sons Inc

Access to resources Recommend Favorite

Continuous Therapy with Sunitinib in Patients with Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. : 485-485

Karger

Access to resources Recommend Favorite